<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39268956</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>13</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>02</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2544-4646</ISSN><JournalIssue CitedMedium="Internet"><Volume>73</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>01</Day></PubDate></JournalIssue><Title>Polish journal of microbiology</Title><ISOAbbreviation>Pol J Microbiol</ISOAbbreviation></Journal><ArticleTitle>Pheno- and Genotypic Epidemiological Characterization of Vancomycin-Resistant <i>Enterococcus faecium</i> Isolates from Intensive Care Unit Patients in Central Türkiye.</ArticleTitle><Pagination><StartPage>403</StartPage><EndPage>410</EndPage><MedlinePgn>403-410</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.33073/pjm-2024-030</ELocationID><Abstract><AbstractText>Vancomycin-resistant <i>Enterococcus faecium</i> (VRE) has been detected in Türkiye. Only limited information is available on its dissemination in the central regions of the country. This study describes the first epidemiological characterization of VRE clinical isolates detected in patients in a hospital in the province of Aksaray. In this one-year study conducted between 2021 and 2022, stool samples from intensive care unit patients were screened for VRE using the phenotypic E-test method, and the antibiotic sensitivity test was analyzed by using the VITEK<sup>®</sup> 2 system. A molecular assay for confirmation of species level was carried out by 16S rRNA gene-based sequencing and testing for antibiotic resistance (<i>van</i>A or <i>van</i>B) and virulence factor-encoding genes (<i>esp, asa1</i>, and <i>hyl</i>). Further, genotypic characterization was determined by macro-restriction fragment pattern analysis (MRFPA) of genomic DNA digested with <i>Sma</i>I restriction enzyme. Of the total 350 <i>Enterococcus</i> positive patients from different hospital intensive care units, 22 (6.3%) were positive for VRE using the phenotypic E-test method. All isolates showed resistance to ampicillin, ciprofloxacin, vancomycin, and teicoplanin and positive amplification for the <i>van</i>A gene. However, none of the isolates was positive for the <i>van</i>B gene. The most prevalent virulence gene was <i>esp</i>. The results indicate that the isolates are persistent in the hospital environment and subsequently transmitted to hospitalized patients, thus representing challenges to an outbreak and infection control. These study results would also help formulate more effective strategies to reduce the transmission and propagation of VRE contamination in various hospital settings.</AbstractText><CopyrightInformation>© 2024 Altan Akineden et al., published by Sciendo.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Akineden</LastName><ForeName>Altan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Clinical Microbiology, Aksaray University Faculty of Medicine, Aksaray, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>ÇiÇek</LastName><ForeName>Cemal</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Education and Research Hospital Aksaray University Faculty of Medicine, Aksaray, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>TÜrkel</LastName><ForeName>SelÇuk</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Education and Research Hospital Aksaray University Faculty of Medicine, Aksaray, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Izhar U H</ForeName><Initials>IUH</Initials><AffiliationInfo><Affiliation>Ottawa Research and Development Centre, Agriculture and Agri-Food Canada, Ottawa, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdulmawjood</LastName><ForeName>Amir</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-5189-8381</Identifier><AffiliationInfo><Affiliation>Institute of Food Quality and Food Safety, University of Veterinary Medicine Hannover, Foundation, Hannover, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Poland</Country><MedlineTA>Pol J Microbiol</MedlineTA><NlmUniqueID>101229003</NlmUniqueID><ISSNLinking>1733-1331</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001426">Bacterial Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D037521">Virulence Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>6Q205EH1VU</RegistryNumber><NameOfSubstance UI="D014640">Vancomycin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012336">RNA, Ribosomal, 16S</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="Y">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016984" MajorTopicYN="Y">Enterococcus faecium</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D065507" MajorTopicYN="Y">Vancomycin-Resistant Enterococci</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016908" MajorTopicYN="Y">Gram-Positive Bacterial Infections</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="Y">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008826" MajorTopicYN="Y">Microbial Sensitivity Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="Y">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001426" MajorTopicYN="Y">Bacterial Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D037521" MajorTopicYN="N">Virulence Factors</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014640" MajorTopicYN="N">Vancomycin</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005243" MajorTopicYN="N">Feces</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012336" MajorTopicYN="N">RNA, Ribosomal, 16S</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020713" MajorTopicYN="N">Vancomycin Resistance</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Enterococcus faecium</Keyword><Keyword MajorTopicYN="N">antimicrobial resistance</Keyword><Keyword MajorTopicYN="N">vanA gene</Keyword><Keyword MajorTopicYN="N">vanB gene</Keyword><Keyword MajorTopicYN="N">vancomycin resistance</Keyword></KeywordList><CoiStatement>Conflict of interest. The authors do not report any financial or personal connections with other persons or organizations, which might negatively affect the contents of this publication and/or claim authorship rights to this publication.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>14</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>14</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>8</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39268956</ArticleId><ArticleId IdType="pmc">PMC11395416</ArticleId><ArticleId IdType="doi">10.33073/pjm-2024-030</ArticleId><ArticleId IdType="pii">pjm-2024-030</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abele-Horn M, Vogel U, Klare I, Konstabel C, Trabold R, Kurihara R, Witte W, Kreth W, Schlegel PG, Claus H. Molecular epidemiology of hospital-acquired vancomycin-resistant enterococci J Clin Microbiol 2006 NaN44(11):4009. doi: 10.1128/jcm.00195-06. . . ; ( ): –. .</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jcm.00195-06</ArticleId><ArticleId IdType="pmc">PMC1698368</ArticleId><ArticleId IdType="pubmed">17005748</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonishyn NA, McDonald RR, Chan EL, Horsman G, Woodmansee CE, Falk PS, Mayhall CG. Evaluation of fluorescence-based amplified fragment length polymorphism analysis for molecular typing in hospital epidemiology: Comparison with pulsed-field gel electrophoresis for typing strains of vancomycin-resistant Enterococcus faecium J Clin Microbiol 2000 NaN38(11):4058. doi: 10.1128/jcm.38.11.4058-4065.2000. . . ; ( ): –. .</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jcm.38.11.4058-4065.2000</ArticleId><ArticleId IdType="pmc">PMC87541</ArticleId><ArticleId IdType="pubmed">11060068</ArticleId></ArticleIdList></Reference><Reference><Citation>Arias CA, Murray BE. The rise of the s: beyond vancomycin resistance Nat Rev Microbiol 2012 NaN10(4):266. doi: 10.1038/nrmicro2761. . . ; ( ): –. .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro2761</ArticleId><ArticleId IdType="pmc">PMC3621121</ArticleId><ArticleId IdType="pubmed">22421879</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthur M, Molinas C, Depardieu F, Courvalin P. Characterization of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147 J Bacteriol 1993 NaN175(1):117. doi: 10.1128/jb.175.1.117-127.1993. . . ; ( ): –. .</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jb.175.1.117-127.1993</ArticleId><ArticleId IdType="pmc">PMC196104</ArticleId><ArticleId IdType="pubmed">8380148</ArticleId></ArticleIdList></Reference><Reference><Citation>Asgin N, Otlu B. Antibiotic resistance and molecular epidemiology of vancomycin-resistant enterococci in a tertiary care hospital in Türkiye Infect Drug Resist 2020 NaN13:191. doi: 10.2147/idr.s191881. . . ; : –. .</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/idr.s191881</ArticleId><ArticleId IdType="pmc">PMC6982448</ArticleId><ArticleId IdType="pubmed">32021333</ArticleId></ArticleIdList></Reference><Reference><Citation>Binici I, Karahocagil MK, Sünnetçioğlu M, Parlak M. [The surveyans of colonisation of vancomycin resistant enterococci and investigation antibiotic susceptibility and risk factors] (in Turkish) Van Med J 2022 NaN29:177. doi: 10.5505/vtd.2022.26428. . . ; : –. .</Citation><ArticleIdList><ArticleId IdType="doi">10.5505/vtd.2022.26428</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonten MJ, Willems R, Weinstein RA. Vancomycin-resistant enterococci: Why are they here, and where do they come from? Lancet Infect Dis 2001 NaN1(5):314. doi: 10.1016/S1473-3099(01)00145-1. . ; ( ): –. .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(01)00145-1</ArticleId><ArticleId IdType="pubmed">11871804</ArticleId></ArticleIdList></Reference><Reference><Citation>Bui MT, Rohde AM, Schwab F, Märtin N, Kipnis M, Boldt AC, Behnke M, Denkel LA, Kola A, Zweigner J, et al. Prevalence and risk factors of colonisation with vancomycin-resistant Enterococci faecium upon admission to Germany’s largest university hospital GMS Hyg Infect Control 2021 NaN16:Doc06. doi: 10.3205/dgkh000377. . . ; : .</Citation><ArticleIdList><ArticleId IdType="doi">10.3205/dgkh000377</ArticleId><ArticleId IdType="pmc">PMC7894188</ArticleId><ArticleId IdType="pubmed">33643773</ArticleId></ArticleIdList></Reference><Reference><Citation>Cattoir V, Leclercq R. Twenty-five years of shared life with vancomycin-resistant enterococci: Is it time to divorce? J Antimicrob Chemother 2013 NaN68(4):731. doi: 10.1093/jac/dks46. . ; ( ): –. .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/dks46</ArticleId><ArticleId IdType="pubmed">23208830</ArticleId></ArticleIdList></Reference><Reference><Citation>Cetinkaya Y, Falk P, Mayhall CG. Vancomycin-resistant enterococci Clin Microbiol Rev 2000 NaN13(4):686. doi: 10.1128/cmr.13.4.686. . . ; ( ): –. .</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/cmr.13.4.686</ArticleId><ArticleId IdType="pmc">PMC88957</ArticleId><ArticleId IdType="pubmed">11023964</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark NC, Cooksey RC, Hill BC, Swenson JM, Tenover FC. Characterization of glycopeptide-resistant enterococci from U.S hospitals. Antimicrob Agents Chemother 1993 NaN37(11):2311. doi: 10.1128/aac.37.11.2311. . . ; ( ): –. .</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/aac.37.11.2311</ArticleId><ArticleId IdType="pmc">PMC192384</ArticleId><ArticleId IdType="pubmed">8285611</ArticleId></ArticleIdList></Reference><Reference><Citation>Coombs GW, Pearson JC, Daley DA, Le T, Robinson OJ, Gottlieb T, Howden BP, Johnson PD, Bennett CM, Stinear TP, et al. Molecular epidemiology of enterococcal bacteremia in Australia J Clin Microbiol 2014 NaN52(3):897. doi: 10.1128/jcm.03286-13. . . ; ( ): –. .</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jcm.03286-13</ArticleId><ArticleId IdType="pmc">PMC3957796</ArticleId><ArticleId IdType="pubmed">24391201</ArticleId></ArticleIdList></Reference><Reference><Citation>Coşkun FA, Mumcuoğlu I, Aksu N, Karahan ZC, Us E, Tekeli FA, Baran I, Kanyılmaz D, Kurşun S. [Phenotypic and genotypic traits of vancomycin-resistant enterococci in a public hospital: the first vanB-positive Enterococcus faecium isolates] (in Turkish) Mikrobiyol Bul 2012 NaN46(2):276. . . ; ( ): –. .</Citation><ArticleIdList><ArticleId IdType="pubmed">22639316</ArticleId></ArticleIdList></Reference><Reference><Citation>Depardieu F, Perichon B, Courvalin P. Detection of the van alphabet and identification of enterococci and staphylococci at the species level by multiplex PCR J Clin Microbiol 2004 NaN42(12):5857. doi: 10.1128/jcm.42.12.5857-5860.2004. . . ; ( ): –. .</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jcm.42.12.5857-5860.2004</ArticleId><ArticleId IdType="pmc">PMC535300</ArticleId><ArticleId IdType="pubmed">15583325</ArticleId></ArticleIdList></Reference><Reference><Citation>Erdem F, Kayacan C, Oncul O, Karagoz A, Aktas Z. Clonal distribution of vancomycin-resistant Enterococcus faecium in Türkiye and the new singleton ST733 J Clin Lab Anal 2020 NaN34(12):e23541. doi: 10.1002/jcla.23541. . . ; ( ): .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcla.23541</ArticleId><ArticleId IdType="pmc">PMC7755804</ArticleId><ArticleId IdType="pubmed">33025699</ArticleId></ArticleIdList></Reference><Reference><Citation>EUCAST The European Committee on Antimicrobial Susceptibility Testing Breakpoint tables for interpretation of MICs and zone diameters. Version 8.0. Basel (Switzerland): The European Committee on Antimicrobial Susceptibility Testing. 2018. . . ; .</Citation></Reference><Reference><Citation>Fisher K, Phillips C. The ecology, epidemiology and virulence of Enterococcus Microbiology 2009 NaN155(6):1749. doi: 10.1099/mic.0.026385-0. . . ; ( ): –. .</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/mic.0.026385-0</ArticleId><ArticleId IdType="pubmed">19383684</ArticleId></ArticleIdList></Reference><Reference><Citation>Gozalan A, Coskun-Ari FF, Ozdem B, Unaldi O, Celikbilek N, Kirca F, Aydogan S, Muderris T, Guven T, Acikgoz ZC, et al. Molecular characterization of vancomycin-resistant Enterococcus faecium strains isolated from carriage and clinical samples in a tertiary hospital, Türkiye J Med Microbiol 2015 NaN64(7):759. doi: 10.1099/jmm.0.000088. . . ; ( ): –. .</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jmm.0.000088</ArticleId><ArticleId IdType="pubmed">25976005</ArticleId></ArticleIdList></Reference><Reference><Citation>Güldemir D, Karagöz A, Dal T, Tekin A, Özekinci T, Durmaz R. [Molecular typing of nosocomial enterococci by pulsed-field gel electrophoresis] (in Turkish) Turk Bull Hyg Exp Biol 2015;72(1):1. doi: 10.5505/turkhijyen.2015.94695. . . ; ( ): - .</Citation><ArticleIdList><ArticleId IdType="doi">10.5505/turkhijyen.2015.94695</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzman Prieto AM, van Schaik W, Rogers MR, Coque TM, Baquero F, Corander J, Willems RJ. Global emergence and dissemination of enterococci as nosocomial pathogens: Attack of the clones? Front Microbiol 2016 NaN7:788. doi: 10.3389/fmicb.2016.00788. . ; : .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2016.00788</ArticleId><ArticleId IdType="pmc">PMC4880559</ArticleId><ArticleId IdType="pubmed">27303380</ArticleId></ArticleIdList></Reference><Reference><Citation>Kacar F, Eroğlu E, Tarakçı A, Çölkesen FD, Armağan ŞÖ, Can S. [Evaluation of Vancomycin resistant enterecoccal infections] (in Turkish) J Turk Soc Intens Care 2022 NaN20(1):44. doi: 10.4274/tybd.galenos.2020.43531. . . ; ( ): –. .</Citation><ArticleIdList><ArticleId IdType="doi">10.4274/tybd.galenos.2020.43531</ArticleId></ArticleIdList></Reference><Reference><Citation>Kılıç FK, Çalkavur Ş, Olukman Ö, Ercan G, Oruç Y, Özkök D, Okur D, Gülfidan G, Devrim İ, Atlıhan F. [Management of vancomycin-resistant enterococci colonization in a neonatal intensive care unit: Lessons from an outbreak] (in Turkish) J Behcet Uz Child Hosp 2012 NaN2(3):148. doi: 10.5222/buchd.2012.148. . . ; ( ): –. .</Citation><ArticleIdList><ArticleId IdType="doi">10.5222/buchd.2012.148</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhnert P, Capaul SE, Nicolet J, Frey J. Phylogenetic positions of Clostridium chauvoei and Clostridium septicum based on 16S rRNA gene sequences Int J Syst Bacteriol 1996 NaN46(4):1174. doi: 10.1099/00207713-46-4-1174. . . ; ( ): –. .</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/00207713-46-4-1174</ArticleId><ArticleId IdType="pubmed">8863454</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S, Stecher G, Li M, Knyaz C, Tamura K. MEGA X: Molecular Evolutionary Genetics Analysis across Computing Platforms Mol Biol Evol 2018 NaN35(6):1547. doi: 10.1093/molbev/msy096. . . ; ( ): –. .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msy096</ArticleId><ArticleId IdType="pmc">PMC5967553</ArticleId><ArticleId IdType="pubmed">29722887</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SC, Lee CW, Shih TC, See LC, Chu CM, Liu YC. Identification of subclinical transmission of vancomycin-resistant enterococcus within an intensive care unit in Taiwan J Microbiol Immunol Infect 2016 NaN49(5):749. doi: 10.1016/j.jmii.2015.11.002. . . ; ( ): –. .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2015.11.002</ArticleId><ArticleId IdType="pubmed">27156242</ArticleId></ArticleIdList></Reference><Reference><Citation>Levitus M, Rewane A, Perera TB.  Vancomycin-resistant enterococci [Internet, updated 2022 May 15] Treasure Island (USA): Stat-Pearls Publishing; 2022.  [cited 2023 May 26]. https://www.ncbi.nlm.nih.gov/books/NBK513233 . : ;  [ ]. Available from.</Citation></Reference><Reference><Citation>Mellmann A, Orth D, Dierich MP, Allerberger F, Klare I, Witte W. Nosocomial cross transmission as a primary cause of vancomycin-resistant enterococci in Austria J Hosp Infect 2000 NaN44(4):281. doi: 10.1053/jhin.1999.0704. . . ; ( ): –. .</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/jhin.1999.0704</ArticleId><ArticleId IdType="pubmed">10772836</ArticleId></ArticleIdList></Reference><Reference><Citation>Peta M, Carretto E, Barbarini D, Zamperoni A, Carnevale L, Perversi L, Pagani M, Bonora MG, Fontana R, Marone P, et al. Outbreak of vancomycin-resistant Enterococcus spp in an Italian general intensive care unit. Clin Microbiol Infect 2006 NaN12(2):163. doi: 10.1111/j.1469-0691.2005.01331.x. . . ; ( ): –. .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-0691.2005.01331.x</ArticleId><ArticleId IdType="pubmed">16441455</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinholt M, Ostergaard C, Arpi M, Bruun NE, Schønheyder HC, Gradel KO, Søgaard M, Knudsen JD, Danish Collaborative Bacteraemia Network (DACOBAN) Incidence, clinical characteristics and 30-day mortality of enterococcal bacteraemia in Denmark 2006-2009: A population-based cohort study Clin Microbiol Infect 2014 NaN20(2):145. doi: 10.1111/1469-0691.12236. . . ; ( ): –. .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1469-0691.12236</ArticleId><ArticleId IdType="pubmed">23647880</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyes K, Bardossy AC, Zervos M. Vancomycin-resistant enterococci: Epidemiology, infection prevention, and control Infect Dis Clin North Am 2016 NaN30(4):953. doi: 10.1016/j.idc.2016.07.009. . . ; ( ): –. .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idc.2016.07.009</ArticleId><ArticleId IdType="pubmed">27660091</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakin F, Aslantaş Ö, Bağcı F. Molecular characterization of vancomycin-resistant Enterococcus faecium isolates from patients admitted to the intensive care unit of Hatay State Hospital Turk J Intensive Care 2019 NaN17(4):204. doi: 10.4274/tybd.galenos.2019.20438. . . ; ( ): –. .</Citation><ArticleIdList><ArticleId IdType="doi">10.4274/tybd.galenos.2019.20438</ArticleId></ArticleIdList></Reference><Reference><Citation>Uludağ Altun H, Ataman Hatipoğlu C, Bulut C, Eser OK, Demiröz AP. [Comparison of GeneXpert® vanA/vanB PCR system and culture methods in the surveillance of vancomycin-resistant enterococci] (in Turkish) Mikrobiyol Bul 2014 NaN48(4):538. doi: 10.5578/mb.8848. . . ; ( ): –. . Turkish.</Citation><ArticleIdList><ArticleId IdType="doi">10.5578/mb.8848</ArticleId><ArticleId IdType="pubmed">25492649</ArticleId></ArticleIdList></Reference><Reference><Citation>USHIESA [Republic of Turkey Ministry of Health General Directorate of Public Health Department of Communicable Diseases and Early Warning Infections Surveillance Network (USHİESA) Summary Report 2020] (in Turkish) Ankara (Türkiye): Ministry of Health; 2021. . . : ; .</Citation></Reference><Reference><Citation>Vankerckhoven V, Van Autgaerden T, Vael C, Lammens C, Chapelle S, Rossi R, Jabes D, Goossens H. Development of a multiplex PCR for the detection of asa1, gelE, cylA, esp, and hyl genes in enterococci and survey for virulence determinants among European hospital isolates of Enterococcus faecium J Clin Microbiol 2004 NaN42(10):4473. doi: 10.1128/jcm.42.10.4473-4479.2004. . . ; ( ): –. .</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jcm.42.10.4473-4479.2004</ArticleId><ArticleId IdType="pmc">PMC522368</ArticleId><ArticleId IdType="pubmed">15472296</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO, ECDC Antimicrobial resistance surveillance in Europe 2022 – 2020 data. Copenhagen (Denmark): WHO Regional Office for Europe; 2022.  [cited 2023 May 30]. WHO Regional Office for Europe and European Centre for Disease Prevention and Controlhttps://www.ecdc.europa.eu/sites/default/files/documents/ECDC-WHO-AMR-report.pdf . . . : ; . [ ]. Available from.</Citation></Reference><Reference><Citation>Willems RJ, Top J, van Santen M, Robinson DA, Coque TM, Baquero F, Grundmann H, Bonten MJ. Global spread of vancomycin-resistant Enterococcus faecium from distinct nosocomial genetic complex Emerg Infect Dis 2005 NaN11(6):821. doi: 10.3201/1106.041204. . . ; ( ): –. .</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/1106.041204</ArticleId><ArticleId IdType="pmc">PMC3367597</ArticleId><ArticleId IdType="pubmed">15963275</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodford N, Johnson AP, Morrison D, Speller DC. Current perspectives on glycopeptide resistance Clin Microbiol Rev 1995 NaN8(4):585. doi: 10.1128/cmr.8.4.585. . . ; ( ): –. .</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/cmr.8.4.585</ArticleId><ArticleId IdType="pmc">PMC172877</ArticleId><ArticleId IdType="pubmed">8665471</ArticleId></ArticleIdList></Reference><Reference><Citation>Yiş R, Aslan S, Cıtak C, Değirmenci S. [Evaluation of vancomycinresistant enterococcus colonization at Gaziantep Children’s Hospital, Türkiye] (in Turkish) Mikrobiyol Bul 2011 NaN45(4):646. . . ; ( ): –. .</Citation><ArticleIdList><ArticleId IdType="pubmed">22090295</ArticleId></ArticleIdList></Reference><Reference><Citation>Zer Y, Bayram A, Akın EÖ, Balcı İ. Analysis of the molecular epidemiology and antibiotic sensitivity of vancomycin-resistant enterococci Eur J Ther 2011 NaN17(2):82. doi: 10.5455/gmj-30-2011-36. . . ; ( ): –. .</Citation><ArticleIdList><ArticleId IdType="doi">10.5455/gmj-30-2011-36</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>